Producers Online
SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received a notice dated September…
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant Approval based on…
Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué, non éligibles à une transplantation Approbation fondée…
VANCOUVER, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR; OTCQB: BHILL) announces that it has elected to issue an…
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific and clinical advances that support optimal treatment options and decisions…
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in treating schizophrenia, including TEV-‘749Currently, there is no long-acting olanzapine treatment…
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
KPMG er staðfestingaraðili vegna almenns tryggingafyrirkomulags Kaldalóns hf. KPMG hefur nú framkvæmt könnun á útreikningum útgefanda á fjárhagslegum og sérstökum skilyrðum skuldabréfa undir almenna tryggingafyrirkomulaginu. Niðurstaða KPMG staðfestir að fjárhagsleg…
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS)…
Westford, USA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Diagnostic Imaging Market Forecast to Grow at 5.4% CAGR from 2024 to 2031 | SkyQuest Technology SkyQuest projects that the Global Diagnostic…